The POINT trial randomized 4, patients with a recent mild stroke or TIA and without atrial fibrillation to treatment with either clopidogrel plus aspirin or aspirin alone for 90 days. Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and aspirin in acute ischemic stroke and.
May 17, Dual Antiplatelet Therapy or Aspirin Alone After TIA or Minor Stroke? However, major hemorrhage occurred more often with clopidogrel.
Dec 20, high-risk transient ischemic attack (TIA) should start dual antiplatelet therapy with aspirin plus clopidogrel as soon as possible after the event.
Jan 1, "Most of the benefit in terms of strokes prevented with dual antiplatelet therapy occurs within the first 10 days after stroke; evidence strongly.
Jun 1, Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE.
Dec 4, The three mimics that are often not obvious on history and physical are . Dual antiplatelet therapy (DAPT) for TIA – again, timing is everything.
Editorial from The New England Journal of Medicine — Dual Antiplatelet Therapy in Acute Transient Ischemic Attack and Minor Stroke.
Nov 26, The Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial was a randomized, double-blind study designed to.
Bottom line: The risk of recurrent stroke or TIA after dual antiplatelet therapy and profile of long-term dual- versus single-antiplatelet therapy among patients.
Dual Antiplatelet Therapy for Minor Stroke and High-Risk Transient Ischemic Attack. What Have We Learned? Liping Liu;, and MD, PhD; Dariush Dowlatshahi .